US Thrombotic Microangiopathy Alliance Logo

MIP Score

39

Health Associations
Cardiovascular Health

US Thrombotic Microangiopathy Alliance

Mission

USTMA is committed to fostering collaboration and forming a true alliance with other advocacy organizations to improve the lives of individuals affected by thrombotic microangiopathy (TMA) in the US. By sharing resources and pooling expertise, USTMA advocates for enhanced care and treatment options, while supporting vital research initiatives.

Basic Information

Tax-Exempt

Address

8056 Baird Rd, Groveport, Ohio, 43125

View all Groveport charities

Founded in

2018

EIN

83-1768842

Total Assets

$797.3 thousand

At a Glance

Understanding TMA

Understanding TMA

Thrombotic microangiopathies are rare but severe conditions that cause organ damage. USTMA raises awareness about these diseases.

Patient Resources

Patient Resources

USTMA provides valuable resources for patients, including access to patient ambassadors and advisories.

Upcoming Patient Meeting

Upcoming Patient Meeting

Join USTMA for the 2024 Patient Meeting in Dallas, Texas, focused on community support and education.

Upcoming Events

TMA Workshop during ASH

TMA Workshop during ASH

December 6, 2024

A workshop dedicated to advancing TMA research and clinical insights.

Learn More
Patient Event - 2024 Patient Meeting

Patient Event - 2024 Patient Meeting

August 16-18, 2024

Annual meeting to foster community among TMA patients.

Learn More
Physician Event - ASH TMA Meeting

Physician Event - ASH TMA Meeting

December 8, 2023

Discussion focused on TMA among physicians.

Learn More

MIP Score (Beta)

The MIP Score is in beta! We'd love any feedback you may have.

The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.

Overall Score

39

26

/100

Program Expense Ratio

54.78%

4

/20

Program Revenue Growth

-100.00%

2

/20

Leverage Ratio

0

2

/20

Working Capital Ratio

2.652

16

/20

Fundraising Efficiency

0

2

/20

Latest Filing Data: Form 990

Fiscal Year:2022

Source:Source: Self-reported by organization

Financial Details

Revenue

CategoryAmountPercentage
Contributions, Gifts, and Grants949.3K99.91%
Program Services00.00%
Investment Income4610.05%
Sales of Non-Inventory Assets00.00%
Other Notable Sources3610.04%
Total Revenue950.1K100.00%